1. Phase II Trial of Temozolomide Plus the Matrix Metalloproteinase Inhibitor, Marimastat, in Recurrent and Progressive Glioblastoma Multiforme
   Morris D. Groves et al, 2002, Journal of Clinical Oncology CrossRef